Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy
Open accessThe DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Abstract
Using nanoparticles to carry and delivery anticancer drugs holds much promise in cancer therapy, but nanoparticles per se are lacking specificity. Active targeting, that is, using specific ligands to functionalize nanoparticles, is attracting much attention in recent years. Aptamers, with their several favorable features like high specificity and affinity, small size, very low immunogenicity, relatively low cost for production, and easiness to store, are one of the best candidates for the specific ligands of nanoparticle functionalization. This review discusses the benefits and challenges of using aptamers to functionalize nanoparticles for active targeting and especially presents nearly all of the published works that address the topic of using aptamers to functionalize nanoparticles for targeted drug delivery and cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R., & Tsourkas, A. (2012) · Science · doi:10.1126/science.1226338 · Cited by 1,322
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Daniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M., & Gold, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136683100 · Cited by 567
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Zhu, G., Zheng, J., Song, E., Donovan, M., Zhang, K., Liu, C., & Tan, W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220817110 · Cited by 546
Cancer nanomedicines: So many papers and so few drugs!
Venditto, V. J., & Szoka, F. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.038 · Cited by 537
Discovery and development of anticancer aptamers
Ireson, C. R., & Kelland, L. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0172 · Cited by 481
Near‐Infrared Light‐Triggered, Targeted Drug Delivery to Cancer Cells by Aptamer Gated Nanovehicles
Yang, X., Liu, X., Liu, Z., Pu, F., Ren, J., & Qu, X. (2012) · Advanced Materials · doi:10.1002/adma.201104797 · Cited by 424
Reversible Cell‐Specific Drug Delivery with Aptamer‐Functionalized Liposomes
Cao, Z., Tong, R., Mishra, A., Xu, W., Wong, G. C. L., Cheng, J., & Lu, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901452 · Cited by 372
A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.
Fujimori, K., Covell, D. G., Fletcher, J. E., & Weinstein, J. N. (1990) · PubMed · Cited by 356
Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer Therapy
Chang, M., Yang, C.-S., & Huang, D.-M. (2011) · ACS Nano · doi:10.1021/nn200693a · Cited by 318
Wang, A. Z., Bagalkot, V., Vasilliou, C. C., Gu, F., Alexis, F., Zhang, L., Shaikh, M., Yuet, K., Cima, M. J., Langer, R., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800091 · Cited by 312
Fujimori, K., Covell, D. G., Fletcher, J. E., & Weinstein, J. N. (1989) · PubMed · Cited by 299
Li, L., Hou, J., Liu, X., Guo, Y., Wu, Y., Zhang, L., & Yang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.019 · Cited by 289
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles
Gao, H., Qian, J., Cao, S., Yang, Z., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.058 · Cited by 280
Ali, E. S., Sharker, S. M., Islam, M. T., Khan, I. N., Shaw, S., Rahman, M. A., Uddin, S. J., Shill, M. C., Rehman, S., Das, N., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.011 · Cited by 267
Building a Multifunctional Aptamer-Based DNA Nanoassembly for Targeted Cancer Therapy
Wu, C., Han, D., Chen, T., Peng, L., Zhu, G., You, M., Qiu, L., Sefah, K., Zhang, X., & Tan, W. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4094617 · Cited by 260
Nanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Cell‐Specific Internalization Study of an Aptamer from Whole Cell Selection
Xiao, Z., Shangguan, D., Cao, Z., Fang, X., & Tan, W. (2008) · Chemistry – A European Journal · doi:10.1002/chem.200701330 · Cited by 246
Yang, L., Tseng, Y.-T., Suo, G., Chen, L., Yu, J., Chiu, W.-J., Huang, C.-C., & Lin, C.-H. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am508117e · Cited by 240
Selective Photothermal Therapy for Mixed Cancer Cells Using Aptamer-Conjugated Nanorods
Huang, Y.-F., Sefah, K., Bamrungsap, S., Chang, H.-T., & Tan, W. (2008) · Langmuir · doi:10.1021/la801969c · Cited by 234
Yu, M. K., Kim, D., Lee, I., So, J., Jeong, Y. Y., & Jon, S. (2011) · Small · doi:10.1002/smll.201100472 · Cited by 225
Xu, W., Siddiqui, I. A., Nihal, M., Pilla, S., Rosenthal, K., Mukhtar, H., & Gong, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.006 · Cited by 223
Miao, L., Newby, J. M., Lin, C. M., Zhang, L., Xu, F., Kim, W. Y., Forest, M. G., Lai, S. K., Milowsky, M. I., Wobker, S. E., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02776 · Cited by 221
Ouyang, C., Zhang, S., Xue, C., Yu, X., Xu, H., Wang, Z., Lu, Y., & Wu, Z.-S. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b09782 · Cited by 208
Liu, J., Wei, T., Zhao, J., Huang, Y., Deng, H., Kumar, A., Wang, C., Liang, Z., Ma, X., & Liang, X.-J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.013 · Cited by 207
Deng, K., Hou, Z., Li, X., Li, C., Zhang, Y., Deng, X., Cheng, Z., & Lin, J. (2015) · Scientific Reports · doi:10.1038/srep07851 · Cited by 206
Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
Salvioni, L., Rizzuto, M. A., Bertolini, J. A., Pandolfi, L., Colombo, M., & Prosperi, D. (2019) · Cancers · doi:10.3390/cancers11121855 · Cited by 201
Xing, H., Tang, L., Yang, X., Hwang, K., Wang, W., Yin, Q., Wong, N. Y., Dobrucki, L. W., Yasui, N., Katzenellenbogen, J. A., et al. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20412j · Cited by 199
AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery
Aravind, A., Jeyamohan, P., Nair, R., Veeranarayanan, S., Nagaoka, Y., Yoshida, Y., Maekawa, T., & Kumar, D. S. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24558 · Cited by 191
Yu, C., Hu, Y., Duan, J., Yuan, W., Wang, C., Xu, H., & Yang, X.-D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024077 · Cited by 190
Xie, X., Li, F., Zhang, H., Lu, Y., Lian, S., Lin, H., Gao, Y., & Jia, L. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.014 · Cited by 185
Aptamers and Their Applications in Nanomedicine
Sun, H., & Zu, Y. (2015) · Small · doi:10.1002/smll.201403073 · Cited by 180
Tang, Y., Hu, H., Zhang, M. G., Song, J., Nie, L., Wang, S., Niu, G., Huang, P., Lu, G., & Chen, X. (2015) · Nanoscale · doi:10.1039/c4nr07493a · Cited by 169
Xiang, D., Shigdar, S., Yang, W., Duan, W., Li, Q., Lin, J., Liu, K., & Li, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s59779 · Cited by 167
Nanomaterial-Enabled Cancer Therapy
Quader, S., & Kataoka, K. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.026 · Cited by 165
Pan, Q., Nie, C., Hu, Y., Yi, J., Liu, C., Zhang, J., He, M., He, M., Chen, T., & Chu, X. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b20707 · Cited by 164
Azhdarzadeh, M., Atyabi, F., Saei, A. A., Varnamkhasti, B. S., Omidi, Y., Fateh, M., Ghavami, M., Shanehsazzadeh, S., & Dinarvand, R. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.02.058 · Cited by 163
Alibolandi, M., Taghdisi, S. M., Ramezani, P., Hosseini Shamili, F., Farzad, S. A., Abnous, K., & Ramezani, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.044 · Cited by 162
Zheng, F.-F., Zhang, P.-H., Xi, Y., Chen, J.-J., Li, L.-L., & Zhu, J.-J. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03131 · Cited by 158
Xiao, Z., Levy-Nissenbaum, E., Alexis, F., Lupták, A., Teply, B. A., Chan, J. M., Shi, J., Digga, E., Cheng, J., Langer, R., et al. (2012) · ACS Nano · doi:10.1021/nn204165v · Cited by 157
Zhao, Y., Wang, J., Cai, X., Ding, P., Lv, H., & Pei, R. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c04363 · Cited by 157
Baek, S. E., Lee, K. H., Park, Y. S., Oh, D., Oh, S., Kim, K., & Kim, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.018 · Cited by 155
Alibolandi, M., Ramezani, M., Abnous, K., Sadeghi, F., Atyabi, F., Asouri, M., Ahmadi, A. A., & Hadizadeh, F. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.026 · Cited by 153
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
Fu, Z., & Xiang, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082793 · Cited by 153
Self-citationLi, F., Mei, H., Gao, Y., Xie, X., Nie, H., Li, T., Zhang, H., & Jia, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.030 · Cited by 152
Gao, H., Qian, J., Yang, Z. H., Pang, Z., Xi, Z., Cao, S., Wang, Y., Pan, S., Zhang, S., Wang, W., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.020 · Cited by 152
Jalalian, S. H., Taghdisi, S. M., Hamedani, N. S., Moosavian, S. A., Lavaee, P., Zandkarimi, M., Ghows, N., Jaafari, M. R., Naghibi, S., Danesh, N. M., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.06.015 · Cited by 147
Li, X., Yang, Y. L., Ji, Q., & Qiu, L. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.08.013 · Cited by 145
Taghavi, S., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.008 · Cited by 145
Alibolandi, M., Ramezani, M., Sadeghi, F., Abnous, K., & Hadizadeh, F. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.035 · Cited by 141
Taghdisi, S. M., Danesh, N. M., Ramezani, M., Lavaee, P., Jalalian, S. H., Robati, R. Y., & Abnous, K. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.03.013 · Cited by 139
He, X., Ren, X., Peng, Y., Zhang, J., Ai, S., Liu, B., Xu, C., & Cheng, S. (2020) · Advanced Materials · doi:10.1002/adma.202000208 · Cited by 139
Alibolandi, M., Hoseini, F., Mohammadi, M., Ramezani, P., Einafshar, E., Taghdisi, S. M., Ramezani, M., & Abnous, K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.052 · Cited by 139
Kim, M. W., Jeong, H. Y., Kang, S. J., Jeong, I. H., Choi, M. J., You, Y. M., Im, C. S., Song, I. H., Lee, T. S., Lee, J. S., et al. (2019) · Theranostics · doi:10.7150/thno.30228 · Cited by 134
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier
Monaco, I., Camorani, S., Colecchia, D., Locatelli, E., Calandro, P., Oudin, A., Niclou, S., Arra, C., Chiariello, M., Cerchia, L., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00527 · Cited by 133
Targeted chemoimmunotherapy using drug-loaded aptamer–dendrimer bioconjugates
Lee, I., An, S., Yu, M. K., Kwon, H., Im, S., & Jon, S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.025 · Cited by 133
Saleh, T., Soudi, T., & Shojaosadati, S. A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.129 · Cited by 130
Lale, S. V., Girija, A. R., Aravind, A., Kumar, D. S., & Koul, V. (2014) · Biomacromolecules · doi:10.1021/bm5001263 · Cited by 125
Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications
Guan, B., & Zhang, X. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s237544 · Cited by 125
Zhen, S., Takahashi, Y., Narita, S., Yang, Y.-C., & Li, X. (2017) · Oncotarget · doi:10.18632/oncotarget.14072 · Cited by 124
Chen, Y., Deng, Y., Zhu, C., & Xiang, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110181 · Cited by 122
Zhao, J., Liu, P., Ma, J., Li, D., Yang, H., Chen, W., & Jiang, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s224160 · Cited by 120
Yu, Z., Ni, M., Xiong, M., Zhang, X., Cai, G., Chen, H., & Zeng, Q. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s78498 · Cited by 119
Das, M., Duan, W., & Sahoo, S. K. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.002 · Cited by 119
Zhuang, Y., Deng, H., Su, Y., He, L., Wang, R., Tong, G., He, D., & Zhu, X. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b00262 · Cited by 117
Pascual, L., Cerqueira‐Coutinho, C., García‐Fernández, A., de Luis, B., Bernardes, E. S., Albernaz, M. D. S., Missailidis, S., Martínez‐Máñez, R., Santos‐Oliveira, R., Orzáez, M., et al. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.08.006 · Cited by 117
Aptamer-Functionalized Gold Nanoparticles As Photoresponsive Nanoplatform for Co-Drug Delivery
Shiao, Y.-S., Chiu, H.-H., Wu, P.-H., & Huang, Y. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5026243 · Cited by 116
Polyvalent Mesoporous Silica Nanoparticle‐Aptamer Bioconjugates Target Breast Cancer Cells
Li, L., Yin, Q., Cheng, J., & Lu, Y. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200116 · Cited by 115
Aptamer-Functionalized Liposomes as a Potential Treatment for Basal Cell Carcinoma
Cadinoiu, A. N., Raţă, D. M., Atanase, L. I., Daraba, O. M., Gherghel, D., Vochița, G., & Popa, M. (2019) · Polymers · doi:10.3390/polym11091515 · Cited by 112
Vandghanooni, S., Eskandani, M., Barar, J., & Omidi, Y. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0205 · Cited by 110
Varnamkhasti, B. S., Hosseinzadeh, H., Azhdarzadeh, M., Vafaei, S. Y., Esfandyari‐Manesh, M., Mirzaie, Z. H., Amini, M., Ostad, S. N., Atyabi, F., & Dinarvand, R. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.060 · Cited by 108
Alibolandi, M., Ramezani, M., Abnous, K., & Hadizadeh, F. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.02.021 · Cited by 108
Wang, K., Yao, H., Meng, Y., Wang, Y., Yan, X., & Huang, R. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.01.002 · Cited by 107
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Subramanian, N., Kanwar, J. R., Athalya, P. K., Janakiraman, N., Khetan, V., Kanwar, R. K., Eluchuri, S., & Krishnakumar, S. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-014-0108-9 · Cited by 105
Bagalkot, V., & Gao, X. (2011) · ACS Nano · doi:10.1021/nn202772p · Cited by 104
Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer
Powell, D., Chandra, S., Dodson, K., Shaheen, F., Wiltz, K., Ireland, S. K., Syed, M., Dash, S., Wiese, T. E., Mandal, T. K., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.01.011 · Cited by 100
Ayatollahi, S., Salmasi, Z., Hashemi, M., Askarian, S., Oskuee, R. K., Abnous, K., & Ramezani, M. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.005 · Cited by 99
Sheng, Y., Bi, X., Yang, L. F., Shan-guang, W., Yu, Y., Jiang, B., Zhang, A., Lan, K., & Duan, S. (2019) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2019.2751 · Cited by 98
Baneshi, M., Dadfarnia, S., Shabani, A. M. H., Sabbagh, S. K., Haghgoo, S., & Bardania, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.025 · Cited by 97
Peng, L., Liang, Y., Zhong, X.-X., Liang, Z., Tian, Y., Li, S., Liang, J., Wang, R., Zhong, Y., Shi, Y., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s238206 · Cited by 97
Li, X., Wu, X., Yang, H., Li, L., Ye, Z., & Rao, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109072 · Cited by 95
Zhang, L., Wang, S., Yang, Z., Hoshika, S., Xie, S., Li, J., Chen, X., Wan, S., Li, L., Benner, S. A., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201909691 · Cited by 95
Yasun, E., Li, C., Barut, I., Janvier, D., Qiu, L., Cui, C., & Tan, W. (2015) · Nanoscale · doi:10.1039/c5nr01704a · Cited by 95
Chen, W., Sung, S. Y., Fadeev, M., Cecconello, A., Nechushtai, R., & Willner, I. (2018) · Nanoscale · doi:10.1039/c8nr00193f · Cited by 94
Zhao, Y., Xu, J., Le, V. M., Gong, Q., Li, S., Gao, F., Ni, L., Liu, J., & Liang, X. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00867 · Cited by 94
Zhao, F., Zhou, J., Su, X., Wang, Y., Yan, X., Jia, S., & Du, B. (2017) · Small · doi:10.1002/smll.201603990 · Cited by 93
Mashreghi, M., Zamani, P., Moosavian, S. A., & Jaafari, M. R. (2020) · Nanoscale Research Letters · doi:10.1186/s11671-020-03334-9 · Cited by 90
Sayari, E., Dinarvand, M., Amini, M., Azhdarzadeh, M., Mollarazi, E., Ghasemi, Z., & Atyabi, F. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.041 · Cited by 90
Ding, L., Li, J., Wu, C., Yan, F., Li, X., & Zhang, S. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01610d · Cited by 87
Chen, Z., Tai, Z., Gu, F., Hu, C., Zhu, Q., & Gao, S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.007 · Cited by 85
Dou, X.-Q., Wang, H., Zhang, J., Wang, F., Xu, G., Xu, C., Xu, H., Xiang, S., Fu, J., & Song, H.-F. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s149887 · Cited by 84
Prusty, D. K., Adam, V., Zadegan, R. M., Irsen, S. H., & Famulok, M. (2018) · Nature Communications · doi:10.1038/s41467-018-02929-2 · Cited by 82
Taghdisi, S. M., Danesh, N. M., Lavaee, P., Emrani, A. S., Hassanabad, K. Y., Ramezani, M., & Abnous, K. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.01.009 · Cited by 81
Cancer cell-selective, clathrin-mediated endocytosis of aptamer decorated nanoparticles
Engelberg, S., Modrejewski, J., Walter, J., Livney, Y. D., & Assaraf, Y. G. (2018) · Oncotarget · doi:10.18632/oncotarget.24772 · Cited by 81
DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics
Latorre, A., Posch, C., Garcimartín, Y., Celli, A., Sanlorenzo, M., Vujic, I., Ma, J. A., Zekhtser, M., Rappersberger, K., Ortiz‐Urda, S., et al. (2014) · Nanoscale · doi:10.1039/c4nr00019f · Cited by 81
Shi, S., Fu, W., Lin, S., Tian, T., Li, S., Shao, X., Zhang, Y., Zhang, T., Tang, Z., Zhou, Y., et al. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102061 · Cited by 80
Li, Z., Liu, Z., Yin, M., Yang, X., Yuan, Q., Ren, J., & Qu, X. (2012) · Biomacromolecules · doi:10.1021/bm301563q · Cited by 79
MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide
Charbgoo, F., Alibolandi, M., Taghdisi, S. M., Abnous, K., Soltani, F., & Ramezani, M. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.12.010 · Cited by 79
Siminzar, P., Omidi, Y., Golchin, A., Aghanejad, A., & Barar, J. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1616745 · Cited by 79
Wei, H., Zhao, Z., Wang, Y., Zou, J., Lin, Q., & Duan, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15874 · Cited by 79
Wang, H., Zhao, X., Guo, C., Ren, D., Zhao, Y., Xiao, W. L., & Jiao, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139136 · Cited by 79
Pi, F., Zhang, H., Li, H., Thiviyanathan, V., Gorenstein, D. G., Sood, A. K., & Guo, P. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.11.015 · Cited by 78
Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery
Xu, L., He, X., Liu, B., Xu, C., Ai, S., Zhuo, R., & Cheng, S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.07.008 · Cited by 77
Chen, F., Zeng, Y., Qi, X., Chen, Y., Ge, Z., Jiang, Z., Zhang, X., Dong, Y., Chen, H., & Yu, Z. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.05.015 · Cited by 77
Zhao, H., Fan, W., Hao, J., Wu, X., Zeng, G. Q., Zhang, L., Nie, S. F., & Wang, X. D. (2014) · Drug Delivery · doi:10.3109/10717544.2014.920059 · Cited by 76
Moosavian, S. A., Abnous, K., Badiee, A., & Jaafari, M. R. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.009 · Cited by 76
Ghasemi, Z., Dinarvand, R., Mottaghitalab, F., Esfandyari‐Manesh, M., Sayari, E., & Atyabi, F. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.12.025 · Cited by 76
Yang, Y., Zhao, W., Tan, W., Lai, Z., Fang, D., Jiang, L., Zuo, C., Yang, N., & Lai, Y. (2019) · Nanoscale Research Letters · doi:10.1186/s11671-019-3208-3 · Cited by 76
Jalalian, S. H., Ramezani, M., Abnous, K., & Taghdisi, S. M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.023 · Cited by 76
Shen, Y., Li, M., Liu, T., Liu, J., Xie, Y., Zhang, J., Xu, S., & Liu, H. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s201688 · Cited by 75
Tao, W., Xu, G., Yu, X., Zhang, J., Sheng, Y., Liu, G., & Mei, L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s103513 · Cited by 74
Duan, T., Xu, Z., Sun, F., Wang, Y., Zhang, J., Luo, C., & Wang, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109121 · Cited by 74
A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery
Leach, J., Wang, A., Ye, K., & Jin, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030380 · Cited by 73
Ding, X., Yin, C., Zhang, W., Sun, Y., Zhang, Z., Yang, E., Sun, D., & Wang, W. (2020) · Nanoscale Research Letters · doi:10.1186/s11671-020-03297-x · Cited by 72
Li, Y., Duo, Y., Bao, S., He, L., Ling, K., Luo, J., Zhang, Y., Huang, H., Zhang, H., & Yu, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s143293 · Cited by 72
Ninomiya, K., Yamashita, T., Kawabata, S., & Shimizu, N. (2014) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2013.12.023 · Cited by 69
Wang, T., Luo, Y., Lv, H., Wang, J., Zhang, Y., & Pei, R. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b16637 · Cited by 67
Yang, S.-D., Ren, Z., Chen, M., Wang, Y., You, B., Chen, W., Qu, C., Liu, Y., & Zhang, X. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01093 · Cited by 66
Gui, K., Zhang, X., Chen, F., Ge, Z., Zhang, S., Qi, X., Sun, J. F., & Yu, Z. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.118 · Cited by 66
Kardani, A., Yaghoobi, H., Alibakhshi, A., & Khatami, M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29584 · Cited by 65
Moosavian, S. A., Abnous, K., Akhtari, J., Arabi, L., Dewin, A. G., & Jafari, M. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1408120 · Cited by 65
Behrooz, A. B., Nabavizadeh, F., Adiban, J., Ardestani, M. S., Vahabpour, R., Aghasadeghi, M. R., & Sohanaki, H. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12670 · Cited by 64
Tekie, F. S. M., Soleimani, M., Zakerian, A., Dinarvand, M., Amini, M., Dinarvand, R., Arefian, E., & Atyabi, F. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.060 · Cited by 64
Belyanina, I. V., Zamay, T. N., Сергеевна, З. Г., Сергеевич, З. С., Kolovskaya, O. S., Ivanchenko, T. I., Денисенко, В. В., Кириченко, А. К., Glazyrin, Y. E., Garanzha, I. V., et al. (2017) · Theranostics · doi:10.7150/thno.17089 · Cited by 64
A Hybrid DNA Aptamer–Dendrimer Nanomaterial for Targeted Cell Labeling
Zhou, J., Soontornworajit, B., Martin, J. T., Sullenger, B. A., Gilboa, E., & Wang, Y. (2009) · Macromolecular Bioscience · doi:10.1002/mabi.200900046 · Cited by 63
Bahreyni, A., Alibolandi, M., Ramezani, M., Sadeghi, A. S., Abnous, K., & Taghdisi, S. M. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.12.006 · Cited by 63
Ryou, S.-M., Yeom, J., Kang, H. J., Won, M., Kim, J., Lee, B., Seong, M., Ha, N., Bae, J., & Lee, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.021 · Cited by 62
Li, F., Mei, H., Xie, X., Zhang, H., Liu, J., Lv, T., Nie, H., Gao, Y., & Jia, L. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0057-9 · Cited by 62
Aghanejad, A., Babamiri, H., Adibkia, K., Barar, J., & Omidi, Y. (2018) · Bioimpacts · doi:10.15171/bi.2018.14 · Cited by 62
Saravanakumar, K., Hu, X., Shanmugam, S., Chelliah, R., Sekar, P., Oh, D., Vijayakumar, S., Kathiresan, K., & Wang, M. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.07.004 · Cited by 59
Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles
Pala, K., Serwotka-Suszczak, A. M., Jeleń, F., Jakimowicz, P., & Otlewski, J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s52539 · Cited by 59
Chakraborty, S., Dlie, Z. Y., Chakraborty, S., Roy, S., Mukherjee, B., Besra, S. E., Dewanjee, S., Mukherjee, A., Ojha, P. K., Kumar, V., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.034 · Cited by 59
Zhou, W., Zhou, Y., Wu, J., Liu, Z., Zhao, H., Liu, J., & Ding, J. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.839683 · Cited by 58
MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells
Hanafi‐Bojd, M. Y., Moosavian, S. A., Taghdisi, S. M., Ansari, L., Abnous, K., & Malaekeh‐Nikouei, B. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1371734 · Cited by 57
Zhao, C., Song, X., Jin, W., Wu, F., Zhang, Q., Zhang, M., Zhou, N., & Shen, J. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.12.045 · Cited by 57
Fang, Y., Lin, S., Yang, F., Situ, J., Lin, S., & Luo, Y. (2020) · BioMed Research International · doi:10.1155/2020/9186583 · Cited by 56
Jiang, J., Chen, H., Yu, C., Zhang, Y., Chen, M., Tian, S., & Sun, C. (2015) · Nanomedicine · doi:10.2217/nnm.15.43 · Cited by 56
Esfandyari‐Manesh, M., Mohammadi, A., Atyabi, F., Nabavi, S. M., Ebrahimi, S. M., Shahmoradi, E., Varnamkhasti, B. S., Ghahremani, M. H., & Dinarvand, R. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.066 · Cited by 55
Chan, M., Huang, W., Wang, J., Liu, R., & Hsiao, M. (2020) · Advanced Science · doi:10.1002/advs.201903741 · Cited by 53
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
Aravind, A., Varghese, S. H., Veeranarayanan, S., Mathew, A., Nagaoka, Y., Iwai, S., Fukuda, T., Hasumura, T., Yoshida, Y., Maekawa, T., et al. (2012) · Cancer Nanotechnology · doi:10.1007/s12645-011-0024-6 · Cited by 53
Perepelyuk, M., Sacko, K., Thangavel, K., & Shoyele, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00900 · Cited by 53
Jin, Y., Wu, Z., Wu, C., Zi, Y., Chu, X., Liu, J., & Zhang, W. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.040 · Cited by 53
Self‐Assembled Aptamer‐Nanomedicine for Targeted Chemotherapy and Gene Therapy
Zhao, N., Zeng, Z., & Zu, Y. (2017) · Small · doi:10.1002/smll.201702103 · Cited by 53
Targeting cancer cells with controlled release nanocapsules based on a single aptamer
Hernández, F. J., Hernandez, L. I., Pinto, A., Schäfer, T., & Özalp, V. C. (2012) · Chemical Communications · doi:10.1039/c2cc37370j · Cited by 52
Song, X., Ren, Y., Zhang, J., WANG, G., Han, X., ZHENG, W., & Zhen, L. (2015) · Oncology Reports · doi:10.3892/or.2015.4136 · Cited by 52
Zeng, Y.-B., Yu, Z., He, Y., Zhang, T., Du, L., Dong, Y., Chen, H., Zhang, Y., & Wang, W. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.166 · Cited by 52
Zhang, Z., Cheng, W., Pan, Y., & Jia, L. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb02284h · Cited by 51
Engelberg, S., Netzer, E., Assaraf, Y. G., & Livney, Y. D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1870-0 · Cited by 51
Du, P., Yan, J., Long, S., Xiong, H., Wen, N., Cai, S., Wang, Y., Peng, D., Liu, Z., & Liu, Y. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00489h · Cited by 50
Yu, Z., Chen, F., Qi, X., Dong, Y., Zhang, Y., Ge, Z., Cai, G., & Zhang, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5578 · Cited by 50
Smith, J. D., Cardwell, L. N., Porciani, D., Nguyen, J. A., Zhang, R., Gallazzi, F., Tata, R. R., Burke, D. H., Daniëls, M. A., & Ulery, B. D. (2018) · Physical Biology · doi:10.1088/1478-3975/aadb68 · Cited by 50
Jo, H., Youn, H., Lee, S., & Ban, C. (2014) · J. Mater. Chem. B · doi:10.1039/c4tb00643g · Cited by 49
Sakhtianchi, R., Darvishi, B., Mirzaie, Z. H., Dorkoosh, F. A., Shanehsazzadeh, S., & Dinarvand, R. (2019) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2019.1569678 · Cited by 49
Ghassami, E., Varshosaz, J., Jahanian‐Najafabadi, A., Minaiyan, M., Rajabi, P., & Hayati, E. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s152474 · Cited by 48
Shoyele, S., Maher, C. M., Lakshmikuttyamma, A., & Perepelyuk, M. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s110488 · Cited by 48
Kalinowska, D., Grabowska‐Jadach, I., Liwinska, M., Drozd, M., Pietrzak, M., Dybko, A., & Brzózka, Z. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.10.069 · Cited by 48
Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy
Jurek, P., Zabłocki, K., Wasko, U. N., Mazurek, M., Otlewski, J., & Jeleń, F. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125231 · Cited by 47
Cellular delivery of shRNA using aptamer-conjugated PLL-alkyl-PEI nanoparticles
Askarian, S., Abnous, K., Taghavi, S., Oskuee, R. K., & Ramezani, M. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.09.023 · Cited by 47
Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting
Ma, J., Zhuang, H., Zhuang, Z., Lu, Y., Xia, R., Gan, L., & Wu, Y. (2017) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2017.1394874 · Cited by 45
Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer
Ma, Q., Qian, W. P., Tao, W., Zhou, Y., & Xue, B. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s210949 · Cited by 44
Zhao, Q., Li, J., Wu, B., Shang, Y., Huang, X., Dong, H., Liu, H., Chen, W., Gui, R., & Nie, X. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c05763 · Cited by 43
Guo, X., Zhu, X., Gao, J., Liu, D., Dong, C., & Jin, X. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0130 · Cited by 43
Tumor cell-specific photothermal killing by SELEX-derived DNA aptamer-targeted gold nanorods
Chandrasekaran, R., Lee, A. S. W., Yap, L. W., Jans, D. A., Wagstaff, K. M., & Cheng, W. (2015) · Nanoscale · doi:10.1039/c5nr07831h · Cited by 42
Wang, H., Zhu, Z., Zhang, G., Lin, F., Liu, Y., Zhang, Y., Feng, J., Chen, W., Meng, Q., & Chen, L. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.017 · Cited by 40
Kolovskaya, O. S., Zamay, T. N., Сергеевна, З. Г., Анатольевич, Б. В., Медведева, Е. Н., Neverova, N. A., Кириченко, А. К., Сергеевич, З. С., Николаевич, Л. И., Morozov, E. V., et al. (2020) · Cancers · doi:10.3390/cancers12010216 · Cited by 39
Chen, H., Tian, J., Liu, D., He, W., & Guo, Z. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02714h · Cited by 38
Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
Yao, F., An, Y., Li, X., Li, Z., Duan, J., & Yang, X. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s240083 · Cited by 38
Fabrication of aptamer modified TiO2 nanofibers for specific capture of circulating tumor cells
Liu, H., Sun, N., Ding, P., Chen, C., Wu, Z., Zhu, W., Liu, L., Wang, Z., & Pei, R. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110985 · Cited by 38
Xu, Z., Ni, R., & Chen, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200482 · Cited by 34
Kaur, J., & Tikoo, K. (2015) · Oncogene · doi:10.1038/onc.2014.447 · Cited by 33
Luo, X., Yang, Y., Kong, F., Zhang, L., & Wei, K. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.013 · Cited by 33
Atabi, F., Gargari, S. L. M., Hashemi, M., & Yaghmaei, P. (2017) · PubMed Central · Cited by 33
Sun, X., Liu, B., Chen, X., Lin, H., Peng, Y., Li, Y., Zheng, H., Xu, Y., Ou, X., Yan, S., et al. (2019) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-019-6278-y · Cited by 32
Zaimy, M. A., Jebali, A., Bazrafshan, B., Mehrtashfar, S., Shabani, S., Tavakoli, A., Hekmatimoghaddam, S., Sarli, A., Azizi, H., Izadi, P., et al. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.33 · Cited by 32
Aptamer-decorated polydiacetylene micelles with improved targeting of cancer cells
Doerflinger, A., Quang, N. N., Gravel, E., Ducongè, F., & Doris, E. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.071 · Cited by 31
Chandra, S., Nguyen, H. M., Wiltz, K., Hall, N., Chaudhry, S., Olverson, G., Mandal, T. K., Dash, S., & Kundu, A. K. (2020) · Journal of Cancer Treatment and Diagnosis · doi:10.29245/2578-2967/2020/1.1176 · Cited by 31
Zhang, Y., Chang, Y.-Q., Han, L., Zhang, Y., Chen, M., Shu, Y., & Wang, J. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01528c · Cited by 31
Liu, W., Zhang, K., Zhuang, L., Liu, J., Zeng, W., Shi, J., & Zhang, Z. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110536 · Cited by 29
Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
Zeng, Z., Tung, C., & Zu, Y. (2020) · Cancers · doi:10.3390/cancers12040780 · Cited by 27
Mie, M., Matsumoto, R., Mashimo, Y., Cass, A. E. G., & Kobatake, E. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4467-2 · Cited by 27
Cabazitaxel liposomes with aptamer modification enhance tumor‑targeting efficacy in nude mice
Cheng, Y., Ou, Z., Li, Q., Yang, J., Hu, M., Zhou, Y., Zhuang, X. A., Zhang, Z. J., & Guan, S. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9689 · Cited by 25
Chen, R., Sun, P., Chu, X., Pu, X., Yang, Y., Zhang, N., & Zhao, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s225142 · Cited by 23
Zhang, Y., Zhao, J., Sun, J., Huang, L., & Li, Q. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6762 · Cited by 23
Lin, H., Li, W.-T., Madanayake, T. W., Tao, C., Niu, Q., Yan, S., Gao, B., & Zhao, P. (2019) · Journal of Biomaterials Applications · doi:10.1177/0885328219882152 · Cited by 23
Aptamer-conjugated DNA nano-ring as the carrier of drug molecules
Vellampatti, S., Heo, R., Babu, M. S., Hyung, P. J., & Park, S. H. (2017) · Nanotechnology · doi:10.1088/1361-6528/aaa3cb · Cited by 22
Jiao, J., ZOU, Q., Zou, M., GUO, R. M., Zhu, S., & ZHANG, Y. (2016) · Neoplasma · doi:10.4149/neo_2016_410 · Cited by 22
Chakraborty, S., Dlie, Z. Y., Mukherjee, B., Besra, S. E., Sengupta, S., Sen, R., & Mukherjee, A. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-1629-z · Cited by 20
Guo, F., Hu, Y. W., Yu, L., Deng, X., Meng, J., Wang, C., & Yang, X. (2016) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2016.10941 · Cited by 19
Guo, W., Mashimo, Y., Kobatake, E., & Mie, M. (2020) · Nanotechnology · doi:10.1088/1361-6528/ab8042 · Cited by 14
Cited by
Kan, X., Wang, J., Li, Y., Li, D., Li, F., Huang, C., & Liu, P. (2026) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2025.115397 · Cited by 3
Metadata
- Authors
- Fu, Z., & Xiang, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-30
- Volume
- 21
- Issue
- 23
- Pages
- 9123
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3108624375
- Cited by
- 231
- References
- 202
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.